| Literature DB >> 31391036 |
Jennifer Erley1, Davide Genovese2,3, Natalie Tapaskar2, Nazia Alvi2,4, Nina Rashedi2, Stephanie A Besser2, Keigo Kawaji2,5, Neha Goyal2, Sebastian Kelle1,6,7, Roberto M Lang2, Victor Mor-Avi2, Amit R Patel8.
Abstract
OBJECTIVES: We sought to: (1) determine the agreement in cardiovascular magnetic resonance (CMR) and speckle tracking echocardiography (STE) derived strain measurements, (2) compare their reproducibility, (3) determine which approach is best related to CMR late gadolinium enhancement (LGE).Entities:
Keywords: Cardiac imaging; Left ventricular function; Myocardial deformation; Myocardial scar
Mesh:
Year: 2019 PMID: 31391036 PMCID: PMC6686365 DOI: 10.1186/s12968-019-0559-y
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Schematic representation of the study design (see text details). Note: the images in the figure highlight the three techniques in a patient with a prior myocardial infarction in the territory of the left anterior descending coronary artery. The transmural late gadolinium enhancement in the mid-distal anterior, mid-distal anteroseptal and distal septum, suggesting lack of viability in these areas, is represented by different colors for the different techniques. FT, feature tracking; GCS, global circumferential strain; GLS, global longitudinal strain; LGE, late gadolinium enhancement; STE, speckle tracking echocardiography; SENC, strain encoding
Fig. 2Example of STE (4Ch) images, showing tracing contours, and corresponding strain curves in a patient with no LGE (a) and a patient with cardiac manifestation of sarcoidosis (b)
Fig. 3Example FT (4Ch, SAX Basal) images, showing tracing contours, and corresponding strain curves in the same two patients a and b as in Fig. 2
Fig. 4Example of SENC (4-Ch, basal short axis) images, showing tracing contours, and corresponding strain curves in the same two patients a and b as in Figs. 2 and 3
Baseline Characteristics of the Patient Population (n = 50)
| Age (years) | 51 ± 9 |
|---|---|
| Female, n (%) | 26 (52%) |
| Median (IQR) BSA (m2) | 1.91 (1.71–2.06) |
| Ischemic heart disease, n (%) | 15 (30%) |
| Non-ischemic heart disease, n (%) | 33 (66%) |
| No cardiac diagnosis, n (%) | 2 (4%) |
| LVEF (from CMR) (%) | 56 (38–61) |
| Median (IQR) LVEDV Index (ml/m2) | 87 (69–113) |
| Median (IQR) LVESV Index (ml/m2) | 37 (30–56) |
| Average LV Mass Index (g/m2) | 61.16 ± 24.95 |
| LGE present, n (%) | 22 (44%) |
| Median (IQR) GLS for Echo ( | −15.8 (−18.9 to −12.1) |
| Median (IQR) GLS for FT (n = 50) | −15.4 (− 18.4 to −10.6) |
| Median (IQR) GLS for SENC (n = 50) | − 14.9 (− 19.3 to − 11.1) |
| Median (IQR) GCS for FT (n = 50) | −14.3 (− 18.3 to − 11.1) |
| Median (IQR) GCS for SENC (n = 50) | − 13.7 (− 15.5 to − 10.8) |
Abbreviations: BSA Body surface area, LVEF left ventricular ejection fraction, LVEDV, LVESV left ventricular end diastolic/end systolic volume, LGE late gadolinium enhancement, GLS global longitudinal strain
Fig. 5Example of LGE (short axis, 4Ch) in the same two patients as in Fig. 2. The ventricle of the patient (a) appears uniformly unenhanced, whereas in the sarcoidosis patient (b), there is diffuse, patchy enhancement in most myocardial segments
Results of the linear- regression and Bland-Altman analyses to determine inter-technique agreement between the different modalities and techniques
| r | p | Bias (%) | LOA (%) | p | |
|---|---|---|---|---|---|
| LV-GLS | |||||
| Echo vs. FT | 0.71 | < 0.001 | 0.9 | −5.8 to 7.6 | 0.07 |
| Echo vs. SENC | 0.75 | < 0.001 | 0.6 | −5.9 to 7.2 | 0.21 |
| FT vs. SENC | 0.81 | < 0.001 | −0.2 | −6.6 to 6.3 | 0.72 |
| LV-GCS | |||||
| FT vs. SENC | 0.67 | < 0.001 | 1.0 | −5.8 to 7.8 | 0.05 |
Results of the Reproducibility Analysis
| ICC | CoV | |||
|---|---|---|---|---|
| Intra-Observer Variability | GLS | STE | 0.94 | 0.07 ± 0.05 |
| FT | 0.89 | 0.13 ± 0.12 | ||
| SENC | 0.99 | 0.04 ± 0.02 | ||
| GCS | FT | 0.98 | 0.03 ± 0.03 | |
| SENC | 0.98 | 0.05 ± 0.05 | ||
| Inter-Observer Variability | GLS | STE | 0.91 | 0.07 ± 0.08 |
| FT | 0.86 | 0.11 ± 0.19 | ||
| SENC | 0.99 | 0.03 ± 0.03 | ||
| GCS | FT | 0.99 | 0.03 ± 0.03 | |
| SENC | 0.94 | 0.08 ± 0.04 |
Median strain values, measured using each technique, in patients without and with LGE and results of the Mann-Whitney test
| Patients without LGE | Patient group with LGE | p | |
|---|---|---|---|
| Echo - GLS | −16.0 (−19.1 to −12.7) | −15.6 (−17.9 to −11.6) | 0.212 |
| FT - GLS | −17.3 (−18.8 to − 13.1) | − 12.5 (15.7 to −10.0) | 0.003 |
| FT - GCS | − 17.8 (− 19.1 to − 13.5) | − 12.0 (−14.3 to − 9.10) | < 0.001 |
| SENC - GLS | −17.3 (− 20.2 to − 14.0) | − 13.5 (− 14.9 to − 10.2) | 0.010 |
| SENC - GCS | −14.8 (− 17.5 to − 12.9) | − 12.4 (− 13.8 to − 8.90) | < 0.001 |
Data presented as median (interquartile range)
Fig. 6Receiver operating characteristic (ROC)- curves depicting the relationship between strain parameters and the presence of LGE
Results of ROC analysis and the univariate logistic regression analysis, demonstrating the association between strain measurements and LGE
| ROC analysis | Univariate logistic regression | |||||
|---|---|---|---|---|---|---|
| AUC | 95% CI | p | OR | 95% CI | p | |
| Echo - GLS | 0.58 | 0.42–0.75 | 0.346 | 1.09 | 0.95–1.24 | 0.213 |
| FT - GLS | 0.67 | 0.52–0.83 | 0.048 | 1.19 | 1.04–1.36 | 0.013 |
| FT - GCS | 0.77 | 0.62–0.91 | 0.003 | 1.30 | 1.11–1.53 | 0.001 |
| SENC - GLS | 0.72 | 0.57–0.88 | 0.011 | 1.18 | 1.04–1.34 | 0.010 |
| SENC - GCS | 0.78 | 0.64–0.91 | 0.002 | 1.41 | 1.14–1.74 | 0.002 |
Results of the multivariate logistic regression analysis for FT (Model 1)- and SENC (Model 2)-derived GLS and GCS, showing the strength of the association between strain measurements and LGE
| OR | 95% CI | p | |
|---|---|---|---|
| Model 1 | |||
| FT - GLS | 0.95 | 0.75–1.22 | 0.696 |
| FT - GCS | 1.35 | 1.01–1.81 | 0.041 |
| Model 2 | |||
| SENC - GLS | 1.02 | 0.86–1.22 | 0.828 |
| SENC - GCS | 1.38 | 1.04–1.82 | 0.025 |